Insights into the current management of dyslipidemia from a clinical pharmacological perspective
Số trang: 11
Loại file: pdf
Dung lượng: 859.14 KB
Lượt xem: 8
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
The low-density lipoprotein cholesterol (LDL-C) is established as a causative agent of atherosclerotic cardiovascular disease (ASCVD) and lowering plasma LDL-C levels represents the main approach to reduce the risk of cardiovascular events. Statins remain the cornerstone of drug therapy for dyslipidemia.
Nội dung trích xuất từ tài liệu:
Insights into the current management of dyslipidemia from a clinical pharmacological perspective
Nội dung trích xuất từ tài liệu:
Insights into the current management of dyslipidemia from a clinical pharmacological perspective
Tìm kiếm theo từ khóa liên quan:
Medicine and pharmacy Atherosclerotic cardiovascular disease Lipid-lowering drugs Familial hypercholesterolemia Nonstatin therapies Lowering plasma LDL-C levelsGợi ý tài liệu liên quan:
-
Validation of a simple HPLC method to quantify methotrexate concentrations in human plasma
6 trang 35 0 0 -
7 trang 35 0 0
-
Assessment of stability of HbA1c levels in human whole blood samples using immunoassays
7 trang 30 0 0 -
Association between sleep quality and internet addiction in high school students
6 trang 30 0 0 -
6 trang 29 0 0
-
Methamphetamine use among people who inject heroin in Hanoi, Vietnam
7 trang 26 0 0 -
Predictors for nursing students' perception of working with older people
7 trang 25 0 0 -
Formulation of chewing gum containing Lactobacillus brevis NB10
12 trang 24 0 0 -
5 trang 22 0 0
-
15 trang 21 0 0